Different effects of tolbutamide and diazoxide in α, and β-cells within intact islets of Langerhans

Diabetes

Volumn 48, Issue 12, 1999, Pages 2390-2397

  Quesada, Ivan ^a   Nadal, Angel ^a   Soria, Bernat ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SULFONYLUREA; TOLBUTAMIDE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; DRUG EFFECT; INSULIN RELEASE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL;

EID: 0033499813     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2390     Document Type: Article

References (45)

1. i, cAMP and phospholipids: derived messengers in coupling mechanism of insulin secretion. Physiol Rev 67:1185-1248, 1987
2. 2+], in single mouse pancreatic β-cells. J Physiol 455:173-186, 1992
3. Ripoll C, Martin F, Rovira JM, Pintor J, Miras-Portugal MT, Soria B: Diadenosine polyphosphates: a novel class of glucose: induced intracellular messengers in the pancreatic β-cell. Diabetes 45:1431-1434, 1996
4. 2+ concentration resembling bursting electrical activity in single mouse islets of Langerhans. FEBS Lett 259:19-23, 1989
5. 2+], oscillations due to bursting electrical activity in single pancreatic islets. Pflügers Arch 418:417-422, 1991
6. i oscillations in mouse pancreatic islets of Langerhans. Diabetes 42:1210-1214, 1993
7. Rosario LM, Atwater I, Scott AM: Pulsatile insulin release and electrical activity from single ob/ob mouse islets of Langerhans. Adv Exp Med Biol 211:413-425, 1986
8. i oscillations induced by ketoisocaproate in single mouse pancreatic islets. Diabetes 44:300-305, 1995
9. + depolarisation. Biochem Biophys Res Commun 228:100-104, 1996
10. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA: Cloning of β-cell high affinity sulphonylurea receptor: a regulator of insulin secretion. Science 268:423-425, 1995
11. KATP: an inward rectifier subunit plus the sulphonylurea receptor. Science 270:1166-1170, 1995
12. Sakura H, Ämmälä C, Smith PA, Gribble FM, Ashcroft FM: Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 377:338-344, 1995
13. Sturgess NC, Ashford MLJ, Cook DL, Hales CN: The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet ii:474-475, 1985
14. + channel in mouse pancreatic β-cells. Pflügers Arch 407:493-499, 1986
15. 2+ concentration in an electrically excitable cell: the insulin secreting pancreatic β-cell. J Biol Chem 267:20713-20720, 1992
16. Gomis A, Valdeolmillos M: Regulation by tolbutamide and diazoxide of the electrical activity in mouse pancreatic β-cells recorded in vivo. Br J Pharmacol 123:443-448, 1998
17. i changes induced by tolbutamide in single pancreatic islets. In Frontiers of Insulin Secretion and Pancreatic β-Cell Research. Flatt P, Lenzen S. Eds. London and Nigati-shi, Japan, Smith-Gordon/Nishimura, 1994, p. 237-241
18. 2+ in β-cells. Diabetes 47:365-373, 1998
19. Ferner RE, Neil HAV: Sulphonylureas and hypoglycaemia. Br Med J 296:949-950, 1988
20. Baker L, Thornton PS, Stanley CA: Management of hyperinsulinism in infants. J Pediatr 119:755-757, 1991
21. + channels in an insulin-secreting cell line. J Memb Biol 99:215-224, 1987
22. + currents recorded from an insulin-secreting cell line. Br J Pharmacol 97:1039-1050, 1989
23. 2+ signaling. Endocrinology 137:693-697, 1996
24. Nadal A, Quesada I, Soria B: Homologous and heterologous asynchronicity between identified α, β and δ cells within intact islets of Langerhans in the mouse. J Physiol 517:85-93, 1999
25. Ipp E, Dobbs RE, Arimura A, Vale W, Harris, Unger RH: Release of immunoreactive somatostatin from pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin and tolbutamide. J Clin Invest 60:760-765, 1977
26. Efendic S, Enzmann F, Nylen A, Uvnas-Wallensten K, Luft R: Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused pancreas. Prof Natl Acad Sci U S A 76:5901-5904, 1979
27. Sako Y, Wasada T, Umeda F, Ibayashi H: Effect of glibenclamide on pancreatic hormone release from isolated perfused islets of normal and cystamine-treated rats. Metabolism 35:944-949, 1986
28. 2 cells. J Gen Physiol 91:223-242, 1988
29. 2+ channels. J Gen Physiol 110:217-228, 1997
30. 2+ oscillations in pancreatic islet cells secreting glucagon and somatostatin. Biochem Biophys Res Commun 208:644-649, 1995
31. 2-cells by insulin/glucose and amino acids. Biochim Biophys Acta 1310:212-216, 1996
32. Edwards JC, Taylor KW: Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim Biophys Acta 215:310-315, 1970
33. Narimiya M, Yamada H, Matsuba I, Ikeda YU, Tanese T, Abe M: The effect of hypoxia on insulin and glucagon secretion in the perfused pancreas of the rat. Endocrinology 111:1010-1014, 1982
34. + channels in clonal pancreatic α cells. J Biol Chem 268:15221-15228, 1993
35. Nadal A, Valdeolmillos M, Soria B: Metabolic regulation of intracellular calcium concentration in mouse pancreatic islet of Langerhans. Am J Physiol 267:E769-E774, 1994
36. Nadal A, Sul JY, Valdeolmillos M, McNaughton PA: Albumin elicits calcium signals from astrocytes in brain slices from neonatal rat cortex. J Physiol 509: 711-716, 1998
37. 2+ concentration dynamics and immunocytochemical staining. Diabetes 47:751-757, 1998
38. Löhrke B, Demo M, Krüger B, Viergutz T, Matthes HD, Jentsch W: Expression of sulphonylurea receptors in bovine monocytes from animals with a different metabolic rate. Pflügers Arch 434:712-720, 1997
39. Gregorio F, Ambrosi F, Cristallini S, Pedetti M, Filipponi P, Santeusanio F: Therapeutical concentrations of tolbutamide, glibenclamide, glicazide and gliquidone at different glucose levels: in vitro effects on pancreatic α and β cell function. Diabetes Res Clin Pract 18:197-206, 1992
40. Pfeifer MA, Beard JC, Halter JB, Judzewitsch R, Best JD, Porte D Jr: Suppression of glucagon secretion during a tolbutamide infusion in normal and non-insulin-dependent diabetic subjects. J Clin Endocrinol Metab 56:586-591, 1983
41. Ostenson CG, Nylen A, Grill V, Gutniak M, Efendic S: Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect. Diabetologia 29:861-867, 1986
42. + channels in a-TC glucagonoma and α-TC insulinoma cells. Diabetes 42:1760-1772, 1993
43. Bode HP, Weber S, Fehmann HC, Göke B: A nutrient-regulated cytosolic calcium oscillator in endocrine pancreatic glucagon-secreting cells. Pflügers Arch 437:324-334, 1999
44. Grimmsmann T, Rustenbeck I: Direct effects of diazoxide on mitochondria in pancreatic β-cells and on isolated liver mitochondria. Br J Pharmacol 123:781-788, 1998
45. Ashcroft FM, Rorsman P: Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol 54:87-143, 1989